External Ventricular Drain Market Demonstrates Long-Term Growth Potential At 6.1% CAGR

The external ventricular drain market is poised for significant growth over the coming years as advancements in neurological care continue. With rising awareness and increasing investments in neurocritical infrastructure, this market is positioned to meet the growing demand for effective management of intracranial pressure and related neurological conditions. Let's explore the market's anticipated value, key players, emerging trends, and important segments shaping its future.

Anticipated Market Value and Growth Outlook for the External Ventricular Drain Market
The external ventricular drain market is projected to expand substantially, reaching a valuation of $6.74 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 6.1% during the forecast period. Several factors are driving this expansion, including the rising prevalence of neurological disorders, increased demand for sophisticated neurocritical care, enhanced investments in neurosurgical infrastructure, heightened awareness surrounding intracranial pressure management, and broader accessibility to specialized neurological hospitals. Key trends influencing market dynamics include the growing use of external ventricular drains in neurocritical care settings, wider adoption of adjustable and continuous EVD systems, increased focus on precise intracranial pressure monitoring, prioritization of infection control in cerebrospinal fluid drainage, and expanding application of EVDs in managing traumatic brain injuries.

Download a free sample of the external ventricular drain market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15808&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Companies Leading the External Ventricular Drain Market
The external ventricular drain marketplace features several influential companies, such as Medtronic Plc, B. Braun SE, Integra LifeSciences, Teleflex Incorporated, Spiegelberg GmbH & Co. KG, IRRAS AB, Sophysa, Raumedic AG, Luciole Medical AG, Fuji Systems Corporation, Ad-Tech Medical Instrument Corporation, Mizuho Medical Co. Ltd., Nipro Corporation, Kaneka Corporation, Samyang Biopharmaceuticals Corporation, Neuromedex GmbH, SILMAG S.A., Tokibo Co. Ltd., Well Lead Medical Co. Ltd., and Beijing Xinlingwei Technology Co. Ltd.
In a notable move in June 2023, Luciole Medical AG, a Swiss medical technology firm, acquired Spiegelberg GmbH & Co. KG, a German manufacturer specializing in catheters and external ventricular drainage kits. This acquisition aims to merge their product portfolios, manufacturing expertise, and distribution channels to strengthen their position as leaders in next-generation brain monitoring technologies.

Innovative Trends Shaping the External Ventricular Drain Market
Leading market players are investing in the development of advanced neurocritical care devices designed to improve patient outcomes and streamline treatment procedures for complex neurological disorders. These devices play a vital role in monitoring and managing critically ill patients, particularly by controlling intracranial pressure and facilitating cerebrospinal fluid drainage.
For example, in March 2025, US-based neurotherapeutic company Anuncia Medical Inc. received FDA Breakthrough Device Designation for its ReFlow External Ventricular Drains. This innovative product introduces a noninvasive, manual flushing system that restores and maintains cerebrospinal fluid flow. The device is user-friendly, allowing nurses to operate it during routine checks, which may reduce ICU stays, prevent additional surgeries, and lower overall costs related to EVD replacements. This breakthrough has expanded Anuncia's product range beyond hydrocephalus treatment into acute neurocritical care, enhancing clinical efficiency and patient care.

View the full external ventricular drain market report:
https://www.thebusinessresearchcompany.com/report/external-ventricular-drain-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Segments Driving the External Ventricular Drain Market Share
This report categorizes the external ventricular drain market into key segments:
1) Product Type: External Ventricular Drainage Sets and Accessories
2) Application Areas: Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, and Other Uses
3) End-User Categories: Hospitals, Specialty Hospitals, Specialty Clinics, and Other Healthcare Facilities
Further breakdown of the product segment includes types of drainage sets such as standard, adjustable, and continuous external ventricular drainage sets. The accessories segment incorporates components like catheters, pressure monitoring devices, drainage bags, and connecting tubes, all contributing to the comprehensive functionality of EVD systems.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.